ReviewFrontiers in oncology2019

Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice.

Petr Szturz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.